Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
iRhom2-mediated proinflammatory signalling regulates heart repair following myocardial infarction
Damien N. Barnette, Thomas J. Cahill, Mala Gunadasa-Rohling, Carolyn A. Carr, Matthew Freeman, Paul R. Riley
Damien N. Barnette, Thomas J. Cahill, Mala Gunadasa-Rohling, Carolyn A. Carr, Matthew Freeman, Paul R. Riley
View: Text | PDF
Research Article Cardiology Immunology

iRhom2-mediated proinflammatory signalling regulates heart repair following myocardial infarction

  • Text
  • PDF
Abstract

The role of proinflammation, and specifically TNF-α, on downstream fibrosis and healing after cardiac injury remains unknown. Using iRhom2-deficient mice, which lack myeloid-specific shedding of TNF-α, we reveal increased macrophages (MΦs) that were skewed towards a more proinflammatory (M1) state at day 4, followed by more reparative, antiinflammatory (M2) state at day 7 after myocardial infarction (MI). However, associated functional cytokine expression was significantly reduced in iRhom2-mutant M1 and M2 MΦs, respectively. A dampened proinflammatory signature in iRhom2-deficient mice during the acute phase of injury and subsequent changes in MΦ polarization were associated with reduced phagocytosis and a more sparse distribution within the scar region. This resulted in impaired collagen deposition and fibrosis, and increased left ventricular remodelling and mortality in iRhom2-deficient mice after MI. Our findings reveal a requirement for an iRhom2-mediated proinflammatory response during downstream scarring and fibrosis, which is driven in part by TNF-α signaling. These conclusions challenge the existing model that infarct repair is determined exclusively by antiinflammatory signaling of M2 MΦs, and as such we propose an alternative view of immunomodulation to maintain effective healing after infarction.

Authors

Damien N. Barnette, Thomas J. Cahill, Mala Gunadasa-Rohling, Carolyn A. Carr, Matthew Freeman, Paul R. Riley

×

Figure 7

Immunophenotyping of BMDMs from iRhom2-deficient mice.

Options: View larger image (or click on image) Download as PowerPoint
Immunophenotyping of BMDMs from iRhom2-deficient mice.
Bone marrow cells...
Bone marrow cells were differentiated in conditioned media for 7 days to generate bone marrow–derived macrophages (BMDMs). Bright-field images revealed (A) wild-type cultures form a dispersed monolayer of cells, (B) while iRhom2-deficient (iRhom2–/–) BMDM cultures formed clusters of cell aggregates (arrowheads). (C) Flow cytometry shows F4/80+ macrophages expressed moderate to high levels of the myeloid differentiation maker CD11b (MFI: 42,758 ± 2,955). However, F4/80+ iRhom2–/– cells expressed low levels of CD11b (MFI: 1,266 ± 64) and increased expression of the monocyte marker Ly6C (MFI: 10,631 ± 716), as well as an increased expression in the late-stage monocyte marker class II MHC (MFI: 34,324 ± 3,687), as compared with wild-type BMDMs (Ly6C MFI: 3,198 ± 1,150; MHCII MFI: 12,733 ± 3,814). (D–F) Phagocytosis assays revealed iRhom2-deficient BMDMs were functionally impaired and failed to phagocytose FITC-labeled latex beads as efficiently as control BMDMs. Scale bars: 200 μm. n = 3 for each experimental group. Data are shown as the mean ± SEM, *P ≤ 0.05, Student’s t test. MFI, mean fluorescence intensity.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts